UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012973
Receipt No. R000014125
Official scientific title of the study Pilot study about utility of blood IgG antibody titer against periodontal pathogen for prediction of development of peri-implantitis
Date of disclosure of the study information 2014/01/27
Last modified on 2016/12/27 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Pilot study about utility of blood IgG antibody titer against periodontal pathogen for prediction of development of peri-implantitis
Title of the study (Brief title) Pilot study about utility of examination for degree of periodontal infection in peri-implantitis
Region
Japan

Condition
Condition Periodontal Disease
Peri-implantitis
Classification by specialty
Dental medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim is to investigate the state about oral implant therapy and to examine about utility of blood IgG antibody titer against periodontal pathogen as infection marker of peri-implantitis.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Test for plasma IgG antibody titer to periodontal pathogen
Key secondary outcomes 1.Items about the patient's information and lifestyle
2. Oral examination: Number of implant, Average holding period of implant (year), The sites of implants in oral[Upper molar region, Upper anterior teeth, Lower molar region, Lower anterior teeth], Presence or absence of a history about tooth loss by periodontal disease, Variation of missing teeth [Kennedy classification],
3.Saliva test for the quantity of periodontal pathogen (PCR method)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Other
Interventions/Control_1 Periodontal patients with oral implant treatment history under Supportive Periodontal Treatment are performed plasma IgG antibody titer to periodontal pathogens once.
Interventions/Control_2 Non-Periodontal patients with oral implant treatment history are performed plasma IgG antibody titer to periodontal pathogens
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Periodontal patients with oral implant treatment history under Supportive Periodontal Treatment

2. Non-Periodontal patients with oral implant treatment history
Key exclusion criteria inflammation in oral cavity
pre-existing diseases
any medication
Target sample size 105

Research contact person
Name of lead principal investigator Shogo Takashiba
Organization Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Biopathological Science
Division name Department of Pathophysiology - Periodontal Science
Address 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan
TEL 086-235-6675
Email stakashi@okayama-u.ac.jp

Public contact
Name of contact person Shogo Takashiba
Organization Okayama University
Division name Department of Pathophysiology - Periodontal Science, Graduate School of Medicine, Dentistry and Phar
Address 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan
TEL 086-235-6675
Homepage URL
Email stakashi@cc.okayama-u.ac.jp

Sponsor
Institute Okayama University
Institute
Department

Funding Source
Organization Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 岡山大学病院,神奈川歯科大学附属病院

Other administrative information
Date of disclosure of the study information
2014 Year 01 Month 27 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 12 Month 27 Day
Anticipated trial start date
2014 Year 01 Month 07 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results https://www.jstage.jst.go.jp/article/shikahozon/59/2/59_178/_pdf
Results Results: Significantly more patients with BRIS were undergoing PSPT than PM. Significantly more patients with plasma IgG antibody titer to Porphyromonas gingivalis (P.g-IgG titer) not less than 1.68 were undergoing PSPT than PM. Also, significantly more patients with Tannerella forsythia in saliva were undergoing PSPT than PM. Significantly more patients with P.g-IgG titer not less than 1.68 and patients with T. forsythia in saliva were undergoing P with BRIS than P without BRIS.

Conclusion: Periodontal bacteria-related examinations using blood and saliva may be useful as prognostic factors for periimplantitis.
Other related information

Management information
Registered date
2014 Year 01 Month 27 Day
Last modified on
2016 Year 12 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014125